SPIRIT-Ayurveda: paper proposes 11 new items for Ayurveda trial protocols

A paper published on Friday, 6 November 2026 in the journal BMC Medical Research Methodology proposes the first steps towards a "SPIRIT-Ayurveda" extension: a set of extra reporting items that researchers would follow when they write the protocol, or advance plan, of a clinical trial of Ayurvedic treatment. The authors, led by Satyajit Pandurang Kulkarni, set out a methodological framework and eleven candidate items. They say the items are meant for future evaluation by a Delphi expert-consensus process, not for immediate use. The work aims to make Ayurveda trials more reproducible and transparent.

A trial protocol is the document researchers write before a study begins. It fixes what will be tested, on whom, how results will be measured and how the data will be analysed. Writing it down in advance, and publishing it, makes it much harder to change the goalposts after the results come in. SPIRIT, short for Standard Protocol Items: Recommendations for Interventional Trials, is the international checklist that tells researchers what such a protocol must contain. Its partner, CONSORT, covers how finished trials are reported.

Ayurveda poses a particular problem for these checklists. A modern drug trial usually tests one pill at one dose against a placebo. An Ayurvedic "whole-system" approach often combines several herbal formulations, diet advice, lifestyle changes and procedures, and adjusts them to the individual patient. If a protocol does not describe that package in enough detail, other researchers cannot repeat the study, and readers cannot tell what exactly was tested. Editorials in Ayurveda research journals have pointed to recurring weaknesses in the field's trials, including small sample sizes, single-centre designs and poor reporting of trial registration, drop-outs and adverse drug events.

Other traditional medicine systems have walked this road before. A SPIRIT extension for Traditional Chinese Medicine was developed through a full Delphi process, and that is the model the new paper points to. An extension for Ayurveda would give journals, ethics committees and funders a common yardstick for judging Ayurvedic trial plans, and the paper suggests the checklist could sit alongside the Ayurveda data items already asked for by India's Clinical Trials Registry.

For readers, the significance is simple: claims about Ayurvedic treatments are only as strong as the studies behind them. Better-planned and better-reported trials make it easier to tell which claims are supported by evidence and which are not. The paper itself makes no claim that any treatment works.

Peepals calculation: If all eleven candidate items were adopted, a protocol for an Ayurvedic trial would need to report 45 items instead of the 34 in SPIRIT 2025 (34 + 11 = 45), about 32% more (11 ÷ 34 ≈ 0.32). Our calculation from the reported figures.

Short-term: Nothing changes yet for researchers. The eleven items are candidates that experts will be asked to rate, refine or reject.

Long-term: If a Delphi process confirms a final list and journals adopt it, Ayurvedic trials would be planned and reported in a more uniform way, making the evidence easier to check and compare with trials of conventional medicine.

Who is affected: Ayurveda researchers and research institutes, ethics committees, journal editors, funders, regulators and, in the end, patients who rely on trial evidence when choosing treatments.

What to watch next: The authors say the next step is a Delphi evaluation of the eleven candidate items.

Questions and Answers